Clinical trial Recruiting at 2 sites Observational Ages 18 to 65

Understanding how E. coli behaves in the human gut

Official title: Study of the Ecological and Evolutionary Dynamics of Escherichia Coli in the Digestive Commensal Flora

Run by Assistance Publique - Hôpitaux de Paris · NCT05153824 · Data updated 2026-11-12

This study is trying to see how E. coli bacteria behave and change in the guts of healthy people to better understand its role in health and disease.

More Escherichia Coli trials

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment200 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Drugs / interventionschemotherapy
Locations2 sites (Paris and 1 other locations)
StatusRecruiting
StartedMarch 2, 2021
Main results expectedMarch 2, 2024
Study endsSeptember 2, 2027
Registry record updatedApril 10, 2023
Trial IDNCT05153824 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are healthy adults aged 18 to 65 with normal gastrointestinal function.

Probably not a fit

Patients with chronic gastrointestinal illnesses or known immunosuppression are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the ecological and evolutionary dynamics of Escherichia coli within the digestive system of healthy individuals. It aims to quantify the changes in E. coli strains in the gut microbiota, focusing on how these changes are influenced by both host and bacterial characteristics. By studying a large population of healthy volunteers, the research seeks to shed light on the colonization dynamics of E. coli, which is crucial for understanding its role in antibiotic resistance and virulence. The study will also explore the intra-host evolution of E. coli over time.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for managing E. coli infections and antibiotic resistance.

How similar studies have gone: While studies on gut microbiota exist, this specific focus on E. coli dynamics in healthy individuals is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* healthy volunteer of both sexes between the ages of 18 and 65 years old included
* subject considered healthy after a thorough general examination (interrogation, physical examination)
* subject with normal transit with usually one molded saddle per day
* BMI between 18.5 and 35 kg / m² included

Exclusion Criteria:

* Subject living in an institution
* Known immunosuppression (HIV, concomitant immunosuppressive therapy, chemotherapy, long-term corticosteroids regardless of the dose\> 2 weeks in the last 6 months)
* Chronic gastrointestinal illness (Chronic Hemorrhagic Recto-colitis, Crohn's Disease)
* Any digestive resection except appendectomy and resection of polyps
* Subject with a history (s) of bacteremia
* Subject protected by law under guardianship or curator-ship
* Pregnant or lactating woman
* Subject deprived of liberty under judicial duress
* Lack of affiliation to a social security scheme
* Patient on State Medical Aid
* Absence of signed consent before entering the study

Where it's running

  • Bichat Claude Bernard Hospital
    Paris, France
    Recruiting
  • Bichat Hospital, Clinical Investigation Center
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.